Investigation of the Effect of Supporting Nursing Care Provided in Line With During Intrapartum Period (Support)

August 29, 2023 updated by: Esra Cevik, Balikesir University

Investigation of the Effect of Supporting Nursing Care Provided in Line With Evidence-Based Practices During Intrapartum Period

Aim: The aim of the research was to examine the effect of supportive nursing care provided in line with evidence-based practices during the intrapartum period.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Methods Design and Settings This study with intervention-control group, randomized and intervention type was carried out in a hospital in Balikesir, located in the west of Turkiye.

Hypotheses Hypothesis 1: Supportive nursing care provided in line with evidence-based practices during the intrapartum period has an effect on the state anxiety level of women.

Hypothesis 2: Supportive nursing care provided in line with evidence-based practices during the intrapartum period has an effect on perceived labor pain.

Hypothesis 3: Supportive nursing care provided in the intrapartum period in line with evidence-based practices has an effect on the duration on birth.

Hypothesis 4: Supportive nursing care provided in line with evidence-based practices in the intrapartum period has an effect on maternal satisfaction.

Universe and sample of the research

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Altıeylül
      • Balıkesir, Altıeylül, Turkey, 10100
        • Balıkesir University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The universe of the research consisted of pregnant women who applied to the delivery unit of a hospital to give birth in Balıkesir, Turkiye. A total of 4634 deliveries took place in this hospital in 2019, of which 2315 were normal deliveries. (https://balikesirism.saglik.gov.tr/ accessed on 2021 Aug 18). The sample size in the study was calculated with the G*power 3.1.9.2 program. Since the scores will be compared in the two dependent groups before and after the intervention, the minimum sample size was calculated as 54, 27 people in each group, based on the two-way hypothesis, 5% type I error, 0.50 Cohen's effect size, and 95% power

Description

Inclusion Criteria:

  • Pregnant women over 18 years of age,
  • with cervical dilatation 3 cm or more,
  • Planned for spontaneous vaginal delivery,
  • Term and singleton pregnancy,
  • Who speak Turkish, who did not have language communication problems,
  • Who voluntarily agreed to participate in the study were included

Exclusion Criteria:

  • Pregnant women with head-pelvis incompatibility
  • Those who gave birth by cesarean section before
  • Pregnant women planned for cesarean delivery
  • Pregnant women with any systemic disease (Diabetes mellitus, hypertension, etc.)
  • Pregnant women who develop fetal distress or hypoxia during labor)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
intervention

Pregnant women over 18 years of age, with cervical dilatation 3 cm or more, planned for spontaneous vaginal delivery, term and singleton pregnancy, who speak Turkish, who did not have language communication problems, and who voluntarily agreed to participate in the study were included.

Pregnant women in the intervention and control groups were randomized using the "www.random.org website" on the computer (intervention=56 control= 56).Intervention and control groups were randomized according to some basic variables (age group, education level, body mass index, number of births and pregnancies, participation in prenatal preparation classes) considering the literature .
Behavioral: supporting nursing care
Supportive nursing care was applied during the intrapartum period. Latent Active Transition phase,birt, postpartum period
Other Names:
  • Supportive nursing care practices in the latent phase Types of supportive care Physical Emotional Informational Advocacy Partner
control

Pregnant women over 18 years of age, with cervical dilatation 3 cm or more, planned for spontaneous vaginal delivery, term and singleton pregnancy, who speak Turkish, who did not have language communication problems, and who voluntarily agreed to participate in the study were included.

During the data collection period of the study, 313 women were evaluated according to the inclusion and exclusion criteria. Women who did not meet the inclusion criteria (n=198) and refused to participate in the study (n=3) were not included in the study sample. Pregnant women in the intervention and control groups were randomized using the "www.random.org website" on the computer (intervention=56 control= 56).Intervention and control groups were randomized according to some basic variables (age group, education level, body mass index, number of births and pregnancies, participation in prenatal preparation classes) considering the literature (Taghenijad et al. 2010; Erdogan et al. 2017).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
positive birth
Time Frame: 2020-2021
The positive birth highlights the importance of woman-centred care to optimize the experience of labour and childbirth for women and their babies through a holistic, human rights-based approach.
2020-2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Balikesir University

Investigators

  • Principal Investigator: ESRA ÇEVİK, https://akademik.yok.gov.tr/AkademikArama/view/viewAuthor.jsp

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2020

Primary Completion (Actual)

December 15, 2020

Study Completion (Actual)

February 15, 2021

Study Registration Dates

First Submitted

July 25, 2023

First Submitted That Met QC Criteria

August 29, 2023

First Posted (Actual)

September 6, 2023

Study Record Updates

Last Update Posted (Actual)

September 6, 2023

Last Update Submitted That Met QC Criteria

August 29, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Balikesir

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delivery;Breech;Stillbirth

Clinical Trials on supporting nursing care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe